Listigo subcutaneous injection 280mg, manufactured by UCB Japan, contains Rozanolixizumab (genetical recombination). This injectable drug (YJ code: 6399432A1028) is supplied as 280mg in 2mL per bottle. It is indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive.
Listigo subcutaneous injection 280mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →